We are excited to announce that BlueSkeye AI has been shortlisted as a finalist for the Medilink Midlands Business Awards 2022.   BlueSkeye AI have been selected as a finalist for the 2022 Medilink Innovation Award category.  The winners of the Awards will be announced at the Award Ceremony held in Nottingham on 27 January 2022.

“We are thrilled to be a finalist in the Medilink Business Awards and that BlueSkeye AiIs  innovative face sensing technology is being recognised for its contribution to improving wellbeing. We are an ethical AI company on a mission to develop AI that you can trust”, said Professor Michel Valstar, CEO of BlueSkeye AI.

The Innovation Award will be given to the company which has developed the most innovative technology, design or process which produces major improvements in business performance and end-user benefits.  

The Medilink Midlands Business awards are a celebration of the best and brightest life sciences companies in the region. There are 8 award categories and you can read about the other shortlisted finalists for all categories here.

If you are interested in attending the event on 27 January, you can register here.

You might also like

Steve Cliffe joins BlueSkeye AI as it scales the development of its technology and customer portfolio.
BlueSkeye AI appoints Steve Cliffe to its board of directors. BlueSkeye has deepened the deep tech expertise on its board by appointing former CEO of Ultraleap, Steve Cliffe as a Non-Executive Director and special advisor.  Steve Cliffe joins BlueSkeye as the company scales and advances its ethical AI technology, partnerships and customer portfolio.  Rebecca Ganz,…
View Article
Read more
TechEntrepreneur PodCast with Michel Valstar
BlueSkeye AI is solving a massive global health problem with ethical AI. BlueSkeye AI is featured in TechEntrepreneur Podcast series. Ton Dobbe, author of the Remarkable Effect, which defines the traits of successful software businesses, interviewed our CEO and co-founder of BlueSkeye AI, Michel Valstar. Ton’s podcast series focuses on software technologies and their founders…
View Article
Read more